News Release

Racial/ethnic disparities in ophthalmology clinical trials of FDA-approved drugs

Peer-Reviewed Publication

JAMA Network

What The Study Did: Researchers investigated racial/ethnic representation in clinical trials that led to U.S. Food and Drug Administration approval of ophthalmology drugs from 2000 to 2020.

Authors: Shriji Patel, M.D., of Vanderbilt University Medical Center in Nashville, Tennessee, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link 


Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full article and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.